Insights

Fifteen+ years of
Healthcare thinking.

Several hundred perspectives on the questions facing payers, providers, biopharma, medtech, and digital health — plus our running read on the clinical literature. Start with our sharpest work, or filter to your world.

An opinionated take on NEJM highlights for November 2019

  • NEJM
A triumph for cystic fibrosis patients (and for Vertex) Phase 3 confir…

Read more